<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "https://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" dtd-version="1.2" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJMABHR</journal-id>
<journal-title-group><journal-title>International Journal of Medical and All Body Health Research</journal-title><abbrev-journal-title>IJMABHR</abbrev-journal-title></journal-title-group>
<issn pub-type="epub">2582-8940</issn>
<publisher><publisher-name>Anfo Publication House</publisher-name></publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">457</article-id>
<article-id pub-id-type="doi">10.54660/IJMBHR.2026.7.2.01-05</article-id>
<title-group><article-title>Incidence Rate of Top Ten Cancers among Iraqi in 2023</article-title></title-group>
<contrib-group>
<contrib contrib-type="author"><name><surname>Khalifa</surname><given-names>Mohammed F</given-names></name><xref ref-type="aff" rid="aff1"/></contrib>
<contrib contrib-type="author"><name><surname>Abbas</surname><given-names>Alaa Abdal-kereem Hussein</given-names></name><xref ref-type="aff" rid="aff2"/></contrib>
<aff id="aff1"><label>1</label>PhD, Department of Technical Pharmacology, Ishtar Technical Medical Institute, Baghdad, Iraq</aff>
<aff id="aff2"><label>2</label>PhD, Instructor, Department of Technical Pharmacology, Ishtar Technical Medical Institute, Baghdad, Iraq</aff>
</contrib-group>
<pub-date publication-format="electronic" date-type="pub"><day>02</day><month>04</month><year>2026</year></pub-date>
<volume>7</volume>
<issue>2</issue>
<fpage>01</fpage>
<lpage>05</lpage>
<history>
<date date-type="received"><day>06</day><month>02</month><year>2026</year></date>
<date date-type="accepted"><day>04</day><month>03</month><year>2026</year></date>
</history>
<permissions><license license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-sa/4.0/?utm"><license-p>CC BY-NC-SA 4.0</license-p></license></permissions>
<self-uri xlink:href="https://www.allmedicaljournal.com/article/457/incidence-rate-of-top-ten-cancers-among-iraqi-in-2023"/>
<self-uri content-type="pdf" xlink:href="https://www.allmedicaljournal.com/article/457/download"/>
<abstract><p>Objective(s): The present study aims at determining the incidence rate of the top ten cancers among Iraqis in 2023.
Methodology: A descriptive, prospective, study is carried throughout the present study to determine the incidence rate of top ten cancers among Iraqis in 2023. convenient sample of (43,062) reported case is included in the study. Such sample is recruited from the records of the Iraqi Council of Cancer Registry Center at the Ministry of Health in Iraq. Incidence rate is computed for each cancer and the reported cases’ demographic characteristics are gathered through the use of demographic data sheet that include age, gender and residency of each reported case.
Results: Analysis of the results depicts that indicate that the incidence rate of cancer is increasing with the age of (70-79) year old. Males develop more bronchus and lung cancer cases and in contrast females develop thyroid cancer cases more than others. The governorate of Erbil has the highest incidence rate of cancers in Iraq 2023.
Conclusion: The study concludes that cancer cases are increasing and so on the incidence rates among Iraqis during the year of 2023 as far as the age is increasing. 
Recommendations: The study recommends that the increasing trend of cancer requires further epidemiological studies to describe incidence by other socio-demographic characteristics in Iraq. Further research, in this area, is essential for understanding the causes underlying these trends and their impact more thoroughly.</p></abstract>
<kwd-group kwd-group-type="author"><kwd>Incidence Rate</kwd><kwd>Top Ten Cancers</kwd><kwd>Iraqis</kwd></kwd-group>
</article-meta>
</front>
<back><ref-list><title>References</title>
<ref id="R1"><label>1</label><mixed-citation>Bray F, Laversanne M, Weiderpass E, Soerjomataram I. The ever-increasing importance of cancer as a leading cause of premature death worldwide. Cancer. 2021;127(16):3029-30. doi:10.1002/cncr.33587</mixed-citation></ref>
<ref id="R2"><label>2</label><mixed-citation>Chen S, Cao Z, Prettner K. Estimates and projections of the global economic cost of 29 cancers in 204 countries and territories from 2020 to 2050. JAMA Oncol. 2023;9(4):465-72. doi:10.1001/jamaoncol.2022.7826</mixed-citation></ref>
<ref id="R3"><label>3</label><mixed-citation>Guida F, Kidman R, Ferlay J. Global and regional estimates of orphans attributed to maternal cancer mortality in 2020. Nat Med. 2022;28(12):2563-72. doi:10.1038/s41591-022-02109-2</mixed-citation></ref>
<ref id="R4"><label>4</label><mixed-citation>Bray F, Laversanne M, Sung H, Ferlay J, Siegel R, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. doi:10.3322/caac.21834</mixed-citation></ref>
<ref id="R5"><label>5</label><mixed-citation>Spronk I, Korevaar J, Poos R, Davids R, Hilderink H, Schellevis F, et al. Calculating incidence rates and prevalence proportions: not as simple as it seems. BMC Public Health. 2019;19:512.</mixed-citation></ref>
<ref id="R6"><label>6</label><mixed-citation>Amen K, Abdullah O, Amin A. Cancer incidence in the Kurdistan Region of Iraq: results of a seven-year cancer registration in Erbil and Duhok Governorates. Asian Pac J Cancer Prev. 2022;23(2):601-15.</mixed-citation></ref>
<ref id="R7"><label>7</label><mixed-citation>Ali H, Edan D, Khamees H, Yasseen N. Epidemiology study for cancer incidences among patients from Baghdad carrying different types of cancer. Iraq J Cancer Med Genet. 2017;10(2):191-5.</mixed-citation></ref>
<ref id="R8"><label>8</label><mixed-citation>Khalifa M, Abdulnabi M. Incidence rate of top ten cancers among children 0-14 year in Iraq 2022. J Curr Med Res Opin. 2025;8(7). doi:10.52845/CMRO/2025/8-7-6</mixed-citation></ref>
<ref id="R9"><label>9</label><mixed-citation>Abul Kareem F, Kamona S. Age-specific and age-standardized incidence trends of Iraq&apos;s top five childhood International Journal of Medical and All Body Health Research www.allmedicaljournal.com cancers (2002–2021). J Health Sustain Dev. 2025. doi:10.58496/</mixed-citation></ref>
<ref id="R10"><label>10</label><mixed-citation>Mokri D, Salah Al-deen M, Khalid S. An insight into the most common cancers in children under the age of 10 years in Kurdistan, Iraq: a cross-sectional study. Medtigo J Med. 2024;2(3).</mixed-citation></ref>
<ref id="R11"><label>11</label><mixed-citation>Salih H, Abd S, Al-Kaseer E, Al-Diwan J. Cancer in Iraq: general view of annual report 2022. J Contemp Med Sci. 2025;10(6). doi:10.22317/jcms.v10i6.1676</mixed-citation></ref>
</ref-list></back>
</article>